Previous studies have reported the resting tremor (RT) of Parkinson's
disease to occur at frequencies between 3-7 Hz and to be characterised
by an alternating pattern of electromyographic (EMG) bursting activit
y between opposing muscles. A postural tremor (PT), of higher frequenc
y (>6 Hz) and with a synchronous pattern of EMG activity, has also bee
n previously described in Parkinson's disease. We investigated the ele
ctrophysiological and pharmacological properties of both the RT and PT
of 11 patients with Parkinson's disease and 10 patients with essentia
l tremor in a double-blind, placebo-controlled study of L-Dopa/bensera
zide and propranolol. Tremor amplitude and frequency were assessed via
bidirectional accelerometry, and the pattern of activation of the ant
agonist muscles of the forearm was determined with use of surface EMG.
In the Parkinson's disease group studied, the frequency, EMG pattern
of bursts, and response to L-Dopa were similar for the two tremors (me
dian improvement of RT by 70% and PT by 61%). Despite some overlap bet
ween the Parkinson's disease and essential tremor groups in the electr
ophysiology of the tremor, there was no such dramatic pharmacological
response in the latter group. These results suggest that the RT and PT
of Parkinson's disease share a common pathophysiology and are distinc
t from essential tremor.